Endoprosthesis Metal Toxicity Study

Summary

Endoprosthesis Metal Toxicity Study is a clinical trial^[1].

Key Facts

• Endoprosthesis Metal Toxicity Study is in the country of United States^[2].
• Endoprosthesis Metal Toxicity Study's instance of is recorded as clinical trial^[3].
• Endoprosthesis Metal Toxicity Study's start time is recorded as +2021-03-12T00:00:00Z^[4].
• Endoprosthesis Metal Toxicity Study's end time is recorded as +2023-01-31T00:00:00Z^[5].
• Endoprosthesis Metal Toxicity Study's contributor to the creative work or subject is recorded as United States National Institutes of Health^[6].
• Endoprosthesis Metal Toxicity Study's contributor to the creative work or subject is recorded as National Heart, Lung, and Blood Institute^[7].
• Endoprosthesis Metal Toxicity Study's sponsor is recorded as Mayo Clinic^[8].
• Endoprosthesis Metal Toxicity Study's main subject is recorded as cognitive dysfunction^[9].
• Endoprosthesis Metal Toxicity Study's number of participants is recorded as {'unit': '1', 'amount': '+150'}^[10].
• Endoprosthesis Metal Toxicity Study's title is recorded as Evaluation and Clinical Impact of Serum and Blood Metal Ion Levels in Patients With an Endoprosthesis^[11].
• Endoprosthesis Metal Toxicity Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Endoprosthesis Metal Toxicity Study's ClinicalTrials.gov ID is recorded as NCT04755140^[13].
• Endoprosthesis Metal Toxicity Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+100'}^[14].
• Endoprosthesis Metal Toxicity Study's research site is recorded as Mayo Clinic^[15].
• Endoprosthesis Metal Toxicity Study's research subject recruitment status is recorded as recruiting^[16].
• Endoprosthesis Metal Toxicity Study's study type is recorded as observational study^[17].